Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 5-[3-(4-Benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzimidazol-2-one | IC50 | 5.3 [1], 35000.0 [2], 100000.0 [3] | |
| 5-[3-[4-[(4-Fluorophenyl)methyl]piperidin-1-yl]prop-1-ynyl]-1,3-dihydrobenzimidazol-2-one | IC50 | 8.2 [1], 38000.0 [2], 100000.0 [3] | |
| 5-(3-(4-Benzylpiperidin-1-yl)prop-1-ynyl)-1-methyl-1H-benzo[d]imidazol-2(3H)-one | IC50 | 62000.0 [1], 89000.0 [2], 100000.0 [3] | |
| 5-[3-[4-[(3-Fluorophenyl)methyl]piperidin-1-yl]prop-1-ynyl]-1,3-dihydrobenzimidazol-2-one | IC50 | 6.1 [1], 100000.0 [2] | |
| 5-[4-(4-Benzylpiperidin-1-yl)but-1-ynyl]-1,3-dihydroindol-2-one | IC50 | 320.0 [1], 52000.0 [2], 100000.0 [3] | |
MLA | "Quest Database™ Glutamate (NMDA) receptor subunit zeta 1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 28 Dec. 2025, https://www.aatbio.com/data-sets/glutamate-nmda-receptor-subunit-zeta-1-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 28). Quest Database™ Glutamate (NMDA) receptor subunit zeta 1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/glutamate-nmda-receptor-subunit-zeta-1-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |